Janus Biotherapeutics
Wellesley, US · Delaware corporation
Founders & leadership
GL
Grayson LipfordNamed on SEC filing
CD
Christine de los ReyesNamed on SEC filing
JR
Jonathan ReisNamed on SEC filing
JB
Joseph BaronNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$668.2K disclosed across 1 round · 2020
▶$668.2KraisedAug 2020 · 8 investors · BiotechnologyRule 506(b)
▶$668.2KraisedAug 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Grayson LipfordExecutive Officer, Director
- Christine de los ReyesDirector
- Jonathan ReisDirector
- Joseph BaronExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $668.2K
- Proceeds to insiders
- $500K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Janus Biotherapeutics raised?
- Janus Biotherapeutics has disclosed $668.2K raised across 1 round.
- Where is Janus Biotherapeutics headquartered?
- Janus Biotherapeutics is headquartered in Wellesley, US.